Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting

Despite the efforts and advances done in the last few decades, cancer still remains one of the main leading causes of death worldwide. Nanomedicine and in particular extracellular vesicles are one of the most potent tools to improve the effectiveness of anticancer therapies. In these attempts, the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barone, Antonella, Zimbo, Anna Maria, d’Avanzo, Nicola, Tolomeo, Anna Maria, Ruga, Stefano, Cardamone, Antonio, Celia, Christian, Scalise, Mariangela, Torella, Daniele, La Deda, Massimo, Iaccino, Enrico, Paolino, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624726/
https://www.ncbi.nlm.nih.gov/pubmed/37365403
http://dx.doi.org/10.1007/s13346-023-01378-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624726/
https://www.ncbi.nlm.nih.gov/pubmed/37365403
http://dx.doi.org/10.1007/s13346-023-01378-9

Ejemplares similares